-
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer
04 Feb 2025 22:22 GMT
… limited-stage small cell lung cancer. If approved, these … in combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond treatment …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… candidate drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after … gemcitabine for treatment of non-small cell lung cancer. …
-
Verastem Oncology Provides a Clinical Update for RAMP 203 Trial in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
18 Dec 2024 12:41 GMT
… mutant advanced non-small cell lung cancer (NSCLC). No dose-limiting … mutant non-small cell lung cancer.”
RAMP 203 Clinical Update … G12C mutant non-small cell lung cancer (NSCLC) who have … avutometinib and defactinib with gemcitabine/nab-paclitaxel in …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … combination with chemotherapy (gemcitabine plus cisplatin) in … for people with lung cancer, including and beyond … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer …
-
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
03 Feb 2025 18:24 GMT
… as a [paclitaxel] or a gemcitabine or any of the non … being explored for small cell lung cancer and neuroendocrine prostate cancer. There …
-
Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy
03 Feb 2025 12:15 GMT
… human non-small cell lung cancer PC9GR cells effectively … al. Synthesis of a gemcitabine-modified phospholipid and its … MDR in breast and lung cancer: discriminating its potential importance … suppresses the development of lung cancer. Tissue Cell. 2022; …
-
Daiichi Sankyo & AstraZeneca's datopotamab deruxtecan recommended for approval in EU to treat patients with previously treated metastatic HR positive, HER2 negative breast cancer
03 Feb 2025 10:20 GMT
… chemotherapy (eribulin, capecitabine, vinorelbine or gemcitabine) in adult patients with unresectable … cancers, including non-small cell lung cancer, triple negative breast cancer and … eight phase 3 trials in lung cancer and five phase 3 trials …
-
Understanding Lung Cancer Stages And Making Informed Treatment Decisions
13 Nov 2024 13:54 GMT
… types of lung cancers are non-small cell lung cancer and small cell lung cancer. Dr … drugs used in lung cancer (NSCLC) are cisplatin, etoposide, carboplatin, gemcitabine, and paclitaxel …
-
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
28 Oct 2024 10:49 GMT
… lung cancer have significantly improved in recent years, lung cancer … -009.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … protein-bound, or gemcitabine and carboplatin) were …
About
© 1995-2025